Ligand ID: 715 Drugbank ID: DB01261(Sitagliptin) Indication:For use as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. Also for use in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin or a PPARγ agonist (e.g., thiazolidinediones) when the single agent alone, with diet and exercise, does not provide adequate glycemic control. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4FFW_A_715A801_1 (DIPEPTIDYL PEPTIDASE4) | 5r7z | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 170SER A 147VAL A 148TYR A 161VAL A 114 | 1.67A | 16.86 | None | ||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 5r7z | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 170SER A 147VAL A 148TYR A 161VAL A 114 | 1.67A | 16.86 | None | ||
![]() | 4FFW_A_715A801_1 (DIPEPTIDYL PEPTIDASE4) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 170SER A 147VAL A 148TYR A 161VAL A 114 | 1.70A | 11.92 | None | ||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 170SER A 147VAL A 148TYR A 161VAL A 114 | 1.69A | 11.92 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | ARG A 298TYR A 209ASN A 214 | 1.18A | 16.19 | DMS A 402 (-3.5A)NoneNone | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | ARG A 298SER A 147TYR A 161 | 1.63A | 16.19 | DMS A 402 (-3.5A)NoneNone | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | ARG A 298TYR A 209ASN A 214 | 1.19A | 16.05 | DMS A 404 (-3.6A)NoneNone | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | ARG A 298SER A 147TYR A 161 | 1.60A | 16.05 | DMS A 404 (-3.6A)NoneNone | ||
![]() | 1X70_A_715A801_1 (DIPEPTIDYL PEPTIDASEIV) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ARG D 298TYR B 118VAL B 114TYR B 126VAL B 125 | 1.73A | 16.00 | None | ||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ARG D 131GLU D 290GLU D 288GLY B 283TYR D 239 | 1.76A | 16.86 | None | ||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 170SER A 147VAL A 148TYR A 161VAL A 114 | 1.70A | 16.86 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 279SER A 239TYR A 238 | 1.23A | 20.00 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6m71 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 33SER A 784TYR A 787 | 1.79A | 20.00 | None | ||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 671TYR A 456SER A 681VAL A 662VAL A 560 | 1.78A | 20.66 | None | ||
![]() | 1X70_A_715A801_1 (DIPEPTIDYL PEPTIDASEIV) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ARG A 654GLU A 658PHE A 348VAL A 560ASN A 568 | 1.19A | 20.00 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ARG C 765TYR C 741ASN B 317 | 0.92A | 21.00 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6vxs | NSP3 (SARS-CoV-2) | 3 / 3 | ARG A 141TYR A 9ASN A 150 | 1.79A | None | |||
![]() | 1X70_B_715B801_1 (DIPEPTIDYL PEPTIDASEIV) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ARG B 190GLU B 96SER B 94VAL B 143ASN B 99 | 1.71A | 20.91 | None | ||
![]() | 1X70_A_715A801_1 (DIPEPTIDYL PEPTIDASEIV) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ARG C 190GLU C 96SER C 94VAL C 143ASN C 99 | 1.68A | 20.91 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ARG B 646SER C 875TYR C 873 | 1.34A | 20.91 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ARG A 765TYR A 741ASN C 317 | 1.22A | 21.40 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ARG C 765TYR C 741ASN B 317 | 1.18A | 21.40 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ARG A 509SER A 366TYR A 369 | 1.20A | 20.91 | None | ||
![]() | 4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE4) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 3 / 3 | PHE C 377TYR C 365TYR C 369 | 1.45A | 12.96 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6w41 | CR3022 FAB HEAVYCHAINSPIKE PROTEIN S1 (Homosapiens;SARS-CoV-2) | 3 / 3 | ARG C 403SER H 55TYR H 52 | 1.66A | 12.95 | None | ||
![]() | 4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE4) | 6w4h | SARS-COV-2 NSP16 (SARS-CoV-2) | 3 / 3 | PHE A6948TYR A7026TYR A6979 | 1.35A | 19.62 | ACT A7104 ( 4.7A)NoneNone | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | ARG C6817TYR C7026ASN C6941 | 1.77A | 12.45 | None | ||
![]() | 4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE4) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | PHE C6948TYR C7026TYR C6979 | 1.33A | 12.45 | FMT C7115 ( 4.3A)NoneNone | ||
![]() | 4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE4) | 6w75 | NSP16 (SARS-CoV-2) | 3 / 3 | PHE A6948TYR A7026TYR A6979 | 1.35A | 12.45 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ARG C 65SER C 85TYR C 83 | 1.09A | 18.23 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ARG A 65SER A 85TYR A 83 | 1.12A | 18.23 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ARG B 65SER B 85TYR B 83 | 1.01A | 18.23 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ARG B 262TYR A 333ASN B 285 | 1.71A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ARG E 276TYR E 298ASN B 345 | 1.52A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ARG E 262TYR E 298ASN B 345 | 1.36A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ARG C 262TYR D 333ASN C 285 | 1.71A | None | |||
![]() | 4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | PHE A6948TYR A7026TYR A6979 | 1.35A | 19.62 | None | ||
![]() | 4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE4) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 3 / 3 | PHE C6948TYR C7026TYR C6979 | 1.34A | 19.62 | None | ||
![]() | 4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE4) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | PHE A6948TYR A7026TYR A6979 | 1.35A | 19.62 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | ARG C6817TYR C7026ASN C6941 | 1.80A | None | |||
![]() | 4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE4) | 6wkq | NSP16 (SARS-CoV-2) | 3 / 3 | PHE C6948TYR C7026TYR C6979 | 1.35A | 19.62 | FMT C7105 ( 4.4A)NoneNone | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ARG A 65SER A 85TYR A 83 | 1.63A | 19.09 | NoneGOL A 507 (-2.9A)None | ||
![]() | 1X70_A_715A801_1 (DIPEPTIDYL PEPTIDASEIV) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ARG A 298TYR B 118VAL B 114TYR B 126VAL B 125 | 1.77A | 16.00 | None | ||
![]() | 4FFW_A_715A801_1 (DIPEPTIDYL PEPTIDASE4) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 170SER A 147VAL A 148TYR A 161VAL A 114 | 1.71A | 10.87 | None | ||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 170SER A 147VAL A 148TYR A 161VAL A 114 | 1.70A | 10.87 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ARG E 408TYR E 451ASN E 501 | 1.76A | None | |||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 170SER A 147VAL A 148TYR A 161VAL A 114 | 1.73A | 16.86 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 3 / 3 | ARG D 141TYR D 9ASN D 150 | 1.77A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 3 / 3 | ARG C 141TYR C 9ASN C 150 | 1.61A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 651TYR A 689ASN A 568 | 1.77A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 132TYR A 163ASN A 138 | 1.65A | None | |||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 279SER A 239TYR A 238 | 1.35A | 20.00 | None | ||
![]() | 4FFW_A_715A801_1 (DIPEPTIDYL PEPTIDASE4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 671TYR A 456SER A 681VAL A 662VAL A 560 | 1.77A | 20.66 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 132TYR A 32ASN A 138 | 1.69A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7btf | NSP12NSP8 (SARS-CoV-2) | 3 / 3 | ARG B 111TYR A 346ASN A 297 | 1.68A | None | |||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 671TYR A 456SER A 681VAL A 662VAL A 560 | 1.74A | 20.66 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | ARG A 298TYR A 209ASN A 214 | 1.28A | DMS A 406 (-3.5A)NoneNone | |||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | ARG A 298SER A 147TYR A 161 | 1.62A | 16.00 | DMS A 406 (-3.5A)NoneNone | ||
![]() | 1X70_B_715B801_2 (DIPEPTIDYL PEPTIDASEIV) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | PHE A 429TYR A 884TYR A 887 | 1.59A | 20.04 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 651TYR A 689ASN A 568 | 1.73A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 132TYR A 163ASN A 138 | 1.58A | None | |||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 249TYR A 238ASN A 312 | 1.16A | None | |||
![]() | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 671TYR A 456SER A 681VAL A 662VAL A 560 | 1.77A | 20.73 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 33SER A 236TYR A 237 | 1.41A | 20.04 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7bv1 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 132TYR A 32ASN A 138 | 1.66A | None | |||
![]() | 1X70_A_715A801_1 (DIPEPTIDYL PEPTIDASEIV) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ARG A 654GLU A 658PHE A 348VAL A 560ASN A 568 | 1.15A | 20.04 | None | ||
![]() | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 33SER A 236TYR A 237 | 1.37A | 20.04 | None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 651TYR A 689ASN A 568 | 1.79A | None U T 12 ( 4.8A)None | |||
![]() | 1X70_A_715A801_1 (DIPEPTIDYL PEPTIDASEIV) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ARG A 654GLU A 658PHE A 348VAL A 560ASN A 568 | 1.25A | 20.04 | NoneNoneNone U T 10 ( 4.6A)None | ||
![]() | 4FFW_B_715B801_2 (DIPEPTIDYL PEPTIDASE4) | 7bv2 | NSP12 (SARS-CoV-2) | 3 / 3 | ARG A 249TYR A 238ASN A 312 | 1.15A | None |